CA Stock MarketDetailed Quotes

Telo Genomics Corp (TELO)

Watchlist
  • 0.050
  • 0.0000.00%
15min DelayMarket Closed Apr 30 16:00 ET
5.02MMarket Cap-2.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telo Genomics Corp (TELO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-14.26%526.62K
-2.00%541.69K
-0.76%2.7M
15.19%690.29K
37.18%845.11K
-26.45%614.22K
-17.81%552.76K
-3.47%2.72M
-29.90%599.25K
-13.34%616.06K
Selling and administrative expenses
5.31%261.73K
19.12%247.37K
-3.73%1.31M
42.19%359.19K
79.43%494.2K
-47.91%248.54K
-41.52%207.66K
-6.64%1.36M
-50.29%252.61K
-32.31%275.42K
-General and administrative expense
5.31%261.73K
19.12%247.37K
-3.73%1.31M
42.19%359.19K
79.43%494.2K
-47.91%248.54K
-41.52%207.66K
-6.64%1.36M
-50.29%252.61K
-32.31%275.42K
Research and development costs
-31.60%264.89K
-14.72%294.32K
2.20%1.39M
-10.88%308.92K
3.19%351.51K
8.18%387.26K
8.70%345.11K
-0.07%1.36M
-0.01%346.65K
12.05%340.64K
Other operating expenses
----
----
----
----
---600
---21.59K
----
----
----
----
Operating profit
14.26%-526.62K
2.00%-541.69K
0.76%-2.7M
-15.19%-690.29K
-37.18%-845.11K
26.45%-614.22K
17.81%-552.76K
3.47%-2.72M
29.90%-599.25K
13.34%-616.06K
Net non-operating interest income (expenses)
Other net income (expenses)
-263.71%-16.37K
10K
0
10K
Special income (charges)
----
----
-263.71%-16.37K
---16.37K
--0
----
----
--10K
--0
--10K
-Less:Impairment of capital assets
----
----
--16.37K
----
----
----
----
--0
----
----
-Less:Other special charges
----
----
----
----
----
----
----
---10K
--0
---10K
Income before tax
14.26%-526.62K
2.00%-541.69K
-0.21%-2.72M
-17.92%-706.66K
-39.44%-845.11K
26.45%-614.22K
17.81%-552.76K
3.82%-2.71M
29.90%-599.25K
14.75%-606.06K
Income tax
Earnings from equity interest net of tax
Net income
14.26%-526.62K
2.00%-541.69K
-0.21%-2.72M
-17.92%-706.66K
-39.44%-845.11K
26.45%-614.22K
17.81%-552.76K
3.82%-2.71M
29.90%-599.25K
14.75%-606.06K
Net income continuous operations
14.26%-526.62K
2.00%-541.69K
-0.21%-2.72M
-17.92%-706.66K
-39.44%-845.11K
26.45%-614.22K
17.81%-552.76K
3.82%-2.71M
29.90%-599.25K
14.75%-606.06K
Noncontrolling interests
Net income attributable to the company
14.26%-526.62K
2.00%-541.69K
-0.21%-2.72M
-17.92%-706.66K
-39.44%-845.11K
26.45%-614.22K
17.81%-552.76K
3.82%-2.71M
29.90%-599.25K
14.75%-606.06K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
14.26%-526.62K
2.00%-541.69K
-0.21%-2.72M
-17.92%-706.66K
-39.44%-845.11K
26.45%-614.22K
17.81%-552.76K
3.82%-2.71M
29.90%-599.25K
14.75%-606.06K
Diluted earnings per share
0.00%-0.01
0.00%-0.01
25.00%-0.03
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.01
20.00%-0.04
50.00%-0.01
0.00%-0.01
Basic earnings per share
0.00%-0.01
0.00%-0.01
25.00%-0.03
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.01
20.00%-0.04
50.00%-0.01
0.00%-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -14.26%526.62K-2.00%541.69K-0.76%2.7M15.19%690.29K37.18%845.11K-26.45%614.22K-17.81%552.76K-3.47%2.72M-29.90%599.25K-13.34%616.06K
Selling and administrative expenses 5.31%261.73K19.12%247.37K-3.73%1.31M42.19%359.19K79.43%494.2K-47.91%248.54K-41.52%207.66K-6.64%1.36M-50.29%252.61K-32.31%275.42K
-General and administrative expense 5.31%261.73K19.12%247.37K-3.73%1.31M42.19%359.19K79.43%494.2K-47.91%248.54K-41.52%207.66K-6.64%1.36M-50.29%252.61K-32.31%275.42K
Research and development costs -31.60%264.89K-14.72%294.32K2.20%1.39M-10.88%308.92K3.19%351.51K8.18%387.26K8.70%345.11K-0.07%1.36M-0.01%346.65K12.05%340.64K
Other operating expenses -------------------600---21.59K----------------
Operating profit 14.26%-526.62K2.00%-541.69K0.76%-2.7M-15.19%-690.29K-37.18%-845.11K26.45%-614.22K17.81%-552.76K3.47%-2.72M29.90%-599.25K13.34%-616.06K
Net non-operating interest income (expenses)
Other net income (expenses) -263.71%-16.37K10K010K
Special income (charges) ---------263.71%-16.37K---16.37K--0----------10K--0--10K
-Less:Impairment of capital assets ----------16.37K------------------0--------
-Less:Other special charges -------------------------------10K--0---10K
Income before tax 14.26%-526.62K2.00%-541.69K-0.21%-2.72M-17.92%-706.66K-39.44%-845.11K26.45%-614.22K17.81%-552.76K3.82%-2.71M29.90%-599.25K14.75%-606.06K
Income tax
Earnings from equity interest net of tax
Net income 14.26%-526.62K2.00%-541.69K-0.21%-2.72M-17.92%-706.66K-39.44%-845.11K26.45%-614.22K17.81%-552.76K3.82%-2.71M29.90%-599.25K14.75%-606.06K
Net income continuous operations 14.26%-526.62K2.00%-541.69K-0.21%-2.72M-17.92%-706.66K-39.44%-845.11K26.45%-614.22K17.81%-552.76K3.82%-2.71M29.90%-599.25K14.75%-606.06K
Noncontrolling interests
Net income attributable to the company 14.26%-526.62K2.00%-541.69K-0.21%-2.72M-17.92%-706.66K-39.44%-845.11K26.45%-614.22K17.81%-552.76K3.82%-2.71M29.90%-599.25K14.75%-606.06K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 14.26%-526.62K2.00%-541.69K-0.21%-2.72M-17.92%-706.66K-39.44%-845.11K26.45%-614.22K17.81%-552.76K3.82%-2.71M29.90%-599.25K14.75%-606.06K
Diluted earnings per share 0.00%-0.010.00%-0.0125.00%-0.030.00%-0.010.00%-0.010.00%-0.010.00%-0.0120.00%-0.0450.00%-0.010.00%-0.01
Basic earnings per share 0.00%-0.010.00%-0.0125.00%-0.030.00%-0.010.00%-0.010.00%-0.010.00%-0.0120.00%-0.0450.00%-0.010.00%-0.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -